T1	Post-eligibility 0 71	Informed consent as documented by signature (see informed consent form)
T2	Condition 73 84	Primary ITP
T3	Measurement 102 126	definition of Rodeghiero
T4	Measurement 145 159	platelet count
T5	Value 163 172	<30x109/l
R1	Has_value Arg1:T4 Arg2:T5	
T6	Scope 102 172	definition of Rodeghiero et al. (52) and a platelet count of <30x109/l
R2	AND Arg1:T6 Arg2:T2	
T7	Person 174 177	Age
T8	Value 185 196	18-45 years
R3	Has_value Arg1:T7 Arg2:T8	
T9	Observation 198 216	Previously treated
T10	Procedure 258 276	first-line therapy
T11	Qualifier 232 239	failure
T12	Qualifier 243 254	intolerance
R4	Has_qualifier Arg1:T10 Arg2:T12	
R5	Has_qualifier Arg1:T10 Arg2:T11	
T13	Condition 281 288	relapse
T14	Temporal 289 313	after first-line therapy
T15	Reference_point 295 313	first-line therapy
T16	Procedure 295 313	first-line therapy
R6	multi Arg1:T15 Arg2:T16	
R7	Has_index Arg1:T14 Arg2:T15	
R8	Has_temporal Arg1:T13 Arg2:T14	
*	OR T10 T13
T17	Drug 320 335	corticosteroids
T18	Drug 337 363	intravenous immunoglobulin
T19	Drug 375 397	anti-D immunoglobulins
*	OR T17 T18 T19
T20	Drug 365 369	IVIG
R9	Subsumes Arg1:T18 Arg2:T20	
